Jun‐Lin Jiang

1.4k total citations
45 papers, 1.1k citations indexed

About

Jun‐Lin Jiang is a scholar working on Physiology, Molecular Biology and Immunology. According to data from OpenAlex, Jun‐Lin Jiang has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 17 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Jun‐Lin Jiang's work include Nitric Oxide and Endothelin Effects (20 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Jun‐Lin Jiang is often cited by papers focused on Nitric Oxide and Endothelin Effects (20 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Jun‐Lin Jiang collaborates with scholars based in China and United States. Jun‐Lin Jiang's co-authors include Chang‐Ping Hu, Yuan‐Jian Li, Han‐Wu Deng, Nian‐Sheng Li, De‐Jian Jiang, Chang-Ping Hu, Gui‐Shan Tan, Jun Peng, Qiong Yuan and Shan Wang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Agricultural and Food Chemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Jun‐Lin Jiang

42 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun‐Lin Jiang China 21 428 322 188 165 130 45 1.1k
Boglárka Laczy Hungary 13 527 1.2× 412 1.3× 132 0.7× 132 0.8× 162 1.2× 32 1.3k
Lan Sun China 25 598 1.4× 208 0.6× 215 1.1× 52 0.3× 116 0.9× 66 1.6k
Reeba K. Vikramadithyan United States 18 654 1.5× 237 0.7× 156 0.8× 141 0.9× 68 0.5× 27 1.2k
Chang-Ping Hu China 27 582 1.4× 187 0.6× 203 1.1× 103 0.6× 326 2.5× 60 1.6k
Giuliana Leoncini Italy 23 406 0.9× 311 1.0× 134 0.7× 313 1.9× 75 0.6× 91 1.4k
Hongli Peng China 15 613 1.4× 287 0.9× 161 0.9× 60 0.4× 112 0.9× 30 1.1k
Lucia Cavallini Italy 23 743 1.7× 329 1.0× 112 0.6× 123 0.7× 54 0.4× 71 1.5k
Ryo Yoshimoto Japan 18 450 1.1× 150 0.5× 137 0.7× 108 0.7× 448 3.4× 43 1.4k
Pankaj K. Bagul India 16 372 0.9× 305 0.9× 108 0.6× 109 0.7× 44 0.3× 18 1.1k

Countries citing papers authored by Jun‐Lin Jiang

Since Specialization
Citations

This map shows the geographic impact of Jun‐Lin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun‐Lin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun‐Lin Jiang more than expected).

Fields of papers citing papers by Jun‐Lin Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun‐Lin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun‐Lin Jiang. The network helps show where Jun‐Lin Jiang may publish in the future.

Co-authorship network of co-authors of Jun‐Lin Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Jun‐Lin Jiang. A scholar is included among the top collaborators of Jun‐Lin Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun‐Lin Jiang. Jun‐Lin Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jiaxu, Zhigang Chen, Chongyang Ma, et al.. (2025). Spatial metabolomics in mental disorders and traditional Chinese medicine: a review. Frontiers in Pharmacology. 16. 1449639–1449639.
2.
Jiang, Jun‐Lin, et al.. (2025). Naringenin inhibits ferroptosis to reduce radiation-induced lung injury: insights from network Pharmacology and molecular docking. Pharmaceutical Biology. 63(1). 1–10. 3 indexed citations
3.
Xie, Xianhong, et al.. (2025). Long non-coding RNA HMGCR suppresses vascular remodeling in streptozotocin-induced type 1 diabetic rats via interaction with THOC5. European journal of medical research. 30(1). 907–907.
4.
Li, Yan, et al.. (2024). The role of cardiomyocyte senescence in cardiovascular diseases: A molecular biology update. European Journal of Pharmacology. 983. 176961–176961. 12 indexed citations
5.
Wang, Yunchao, Jun‐Lin Jiang, & Zhongxin Zhu. (2024). Trends in disease burden of type 2 diabetes, stroke, and hypertensive heart disease attributable to high BMI in China: 1990–2019. Open Medicine. 19(1). 20241087–20241087.
6.
Xie, Yao, Le Xie, Jun‐Lin Jiang, et al.. (2023). Beneficial effects and safety of traditional Chinese medicine for chronic inflammatory demyelinating polyradiculoneuropathy: A case report and literature review. Frontiers in Neurology. 14. 1126444–1126444. 1 indexed citations
7.
Wu, Meiting, Ting Li, Ge Li, et al.. (2023). LncRNA DANCR deficiency promotes high glucose-induced endothelial to mesenchymal transition in cardiac microvascular cells via the FoxO1/DDAH1/ADMA signaling pathway. European Journal of Pharmacology. 950. 175732–175732. 11 indexed citations
8.
Niu, Bingxuan, Xu Xie, Xiao-Ming Xiong, & Jun‐Lin Jiang. (2021). Network pharmacology-based analysis of the anti-hyperglycemic active ingredients of roselle and experimental validation. Computers in Biology and Medicine. 141. 104636–104636. 30 indexed citations
9.
10.
Zhao, Weichen, Ge Li, Chuyi Huang, & Jun‐Lin Jiang. (2019). Asymmetric dimethylarginine: An crucial regulator in tissue fibrosis. European Journal of Pharmacology. 854. 54–61. 11 indexed citations
11.
Yang, Zhong‐Bao, Tingbo Li, Zheng Lou, et al.. (2014). Protective effect of vitexin compound B-1 against hypoxia/reoxygenation-induced injury in differentiated PC12 cells via NADPH oxidase inhibition. Naunyn-Schmiedeberg s Archives of Pharmacology. 387(9). 861–871. 28 indexed citations
12.
Hu, Chang‐Ping, et al.. (2012). Cardiovascular risk in autoimmune disorders: Role of asymmetric dimethylarginine. European Journal of Pharmacology. 696(1-3). 5–11. 16 indexed citations
13.
Wang, Shan, Chang‐Ping Hu, Qiong Yuan, et al.. (2012). Dimethylarginine dimethylaminohydrolase 1 regulates nerve growth factor‐promoted differentiation of PC12 cells in a nitric oxide‐dependent but asymmetric dimethylargenine‐independent manner. Journal of Neuroscience Research. 90(6). 1209–1217. 8 indexed citations
14.
Jiang, Jun‐Lin, Xiaohong Zhang, Nian‐Sheng Li, et al.. (2006). Probucol Decreases Asymmetrical Dimethylarginine Level by Alternation of Protein Arginine Methyltransferase I and Dimethylarginine Dimethylaminohydrolase Activity. Cardiovascular Drugs and Therapy. 20(4). 281–294. 30 indexed citations
15.
Yang, Tianlun, et al.. (2005). Fenofibrate decreases asymmetric dimethylarginine level in cultured endothelial cells by inhibiting NF-κB activity. Naunyn-Schmiedeberg s Archives of Pharmacology. 371(5). 401–407. 28 indexed citations
16.
Yang, Tianlun, Meifang Chen, Bailing Luo, et al.. (2004). Effect of fenofibrate on LDL-induced endothelial dysfunction in rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 370(2). 79–83. 17 indexed citations
17.
Jiang, De‐Jian, Jun‐Lin Jiang, Gui‐Shan Tan, et al.. (2003). Protective effects of daviditin A against endothelial damage induced by lysophosphatidylcholine. Naunyn-Schmiedeberg s Archives of Pharmacology. 367(6). 600–606. 38 indexed citations
18.
Jiang, De‐Jian, et al.. (2003). Relationship between protective effect of xanthone on endothelial cells and endogenous nitric oxide synthase inhibitors. Bioorganic & Medicinal Chemistry. 11(23). 5171–5177. 30 indexed citations
19.
Jiang, Jun‐Lin, Nian‐Sheng Li, Yuan‐Jian Li, & Han‐Wu Deng. (2002). Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level. British Journal of Pharmacology. 135(5). 1175–1182. 88 indexed citations
20.
Zhou, Zhihong, Jun‐Lin Jiang, Jun Peng, Han‐Wu Deng, & Yuanjian Li. (2002). Reversal of tolerance to nitroglycerin with N-acetylcysteine or captopril: a role of calcitonin gene-related peptide. European Journal of Pharmacology. 439(1-3). 129–134. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Boglárka Laczy Breakdown of academic impact, for papers by Lan Sun Breakdown of academic impact, for papers by Reeba K. Vikramadithyan Breakdown of academic impact, for papers by Chang-Ping Hu Breakdown of academic impact, for papers by Giuliana Leoncini Breakdown of academic impact, for papers by Hongli Peng Breakdown of academic impact, for papers by Lucia Cavallini Breakdown of academic impact, for papers by Ryo Yoshimoto Breakdown of academic impact, for papers by Pankaj K. Bagul
Rankless by CCL
2026